GL
Healthcare & Life Sciences
Glycomimetics
United States
Glycomimetics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Glycomimetics
Based in the United States, Glycomimetics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Glycomimetics is a clinical-stage biotechnology company developing novel therapies targeting glycomimetic molecules to treat diseases such as cancer and sickle cell disease.
Explore Glycomimetics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.